Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research and Treatment
Published in: Breast Cancer Research and Treatment 1/2003

01-07-2003

A Phase II Study of Topical Ceramides for Cutaneous Breast Cancer

Authors: Aminah Jatoi, Vera J. Suman, Paul Schaefer, Margaret Block, Charles Loprinzi, Patrick Roche, Stuart Garneau, Roscoe Morton, Philip J. Stella, Steven R. Alberts, Mark Pittelkow, Jeff Sloan, Richard Pagano

Published in: Breast Cancer Research and Treatment | Issue 1/2003

Login to get access
Metadata
Title
A Phase II Study of Topical Ceramides for Cutaneous Breast Cancer
Authors
Aminah Jatoi
Vera J. Suman
Paul Schaefer
Margaret Block
Charles Loprinzi
Patrick Roche
Stuart Garneau
Roscoe Morton
Philip J. Stella
Steven R. Alberts
Mark Pittelkow
Jeff Sloan
Richard Pagano
Publication date
01-07-2003
Publisher
Kluwer Academic Publishers
Published in
Breast Cancer Research and Treatment / Issue 1/2003
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1023/A:1024409123726

Other articles of this Issue 1/2003

Breast Cancer Research and Treatment 1/2003 Go to the issue

OriginalPaper

Breast Cancer Metastasis Alters Acetylcholinesterase Activity and the Composition of Enzyme Forms in Axillary Lymph Nodes

OriginalPaper

Proteomic Characterization of Nipple Aspirate Fluid: Identification of Potential Biomarkers of Breast Cancer

OriginalPaper

Estrogen Receptor Alpha Gene Polymorphisms and Breast Cancer Risk

OriginalPaper

Molecular Characterization of Oncostatin M-induced Growth Arrest of MCF-7 Cells Expressing a Temperature-Sensitive Mutant of p53

OriginalPaper

Tumor Necrosis Factor-α Induces Interleukin-6 Production via Extracellular-Regulated Kinase 1 Activation in Breast Cancer Cells

OriginalPaper

High Serum YKL-40 Levels in Patients with Primary Breast Cancer is Related to Short Recurrence Free Survival
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits